Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Molecular Dynamics Inc.

Division of General Electric Co.

Latest From Molecular Dynamics Inc.

Silicon Genetics

Now that there is a growing number of labs producing gene expression data, researchers find themselves in need of better software tools to make sense of the data. So Silicon Genetics came out with {GeneSpring}, to allow complex comparisons among genes, allowing scientists to figure out, for example, what genes behave in similar ways.
BioPharmaceutical Research and Development Strategies

Kiva Genetics Inc. (Now DNA Sciences Inc.)

While gene sequencing and gene expression technologies have become relatively industrialized, genetic analysis is a time-consuming, labor intensive, and rate-limiting step in drug discovery. Kiva Genetics hopes to remove this bottleneck with a high-throughput system that miniaturizes and automates genotyping.
BioPharmaceutical Platform Technologies

Quantum Dot Corp.

Profile of company using the silicone valley technology of quantum dots to create more precise and versatile biological assays.
BioPharmaceutical Business Strategies

Incyte Jumps Into Genome Mapping; Investors Jump out

Incyte Pharmaceuticals Inc. purchases Hexagen and creates a new business unit, Incyte Genetics, to be publicly traded as a tracking stock. Incyte Gentics' mission: to map the human genome within a year and generate SNP data for every human gene.
BioPharmaceutical Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • General Electric Co.
  • Senior Management
  • Jay Flatley, Pres. & CEO
    Lynne Wagoner, Dir., Fin.
    Bud Bromley, SVP, Sales & Mktg.
    David Barker, PhD, VP, Research & Bus. Dev.
  • Contact Info
  • Molecular Dynamics Inc.
    Phone: (408) 773-1222
    928 E. Arques Ave.
    Sunnyvale, CA 94086-4536